Planned clinical trial of Staccato inhaled zaleplon for the treatment of patients with insomnia.
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Zaleplon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Alexza Pharmaceuticals
- 06 Nov 2012 Status changed from planning to suspended, as reported in an Alexza Pharmaceuticals media release.
- 13 Jul 2010 New trial record